The aims of this study were to evaluate: (1) whether monoaminergic inhibition increases BDNF in vivo and in vitro as predicted by the neurotrophic hypothesis of depression, and (2) whether a triple reuptake inhibition approach has a superior BDNF response compared to a dual reuptake inhibitor approach. Here, BDNF is linked to depressive disorder.